Tuesday, January 20, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Xponential Fitness Reports Strong Sales Growth in Q4 2023 and Outlines Ambitious Plans for 2024

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Fitness app
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Xponential Fitness, a leading fitness company, released its fourth-quarter 2023 earnings on February 29, 2024. The company reported an adjusted EPS of $0.080, which was below the analyst consensus estimate of $0.150 by 46.67%. However, Xponential Fitness exceeded expectations in terms of quarterly sales, generating $90.195 million compared to the estimated $81.892 million, marking a 10.14% increase.

During Q4 2023, Xponential Fitness experienced significant growth, with a 27% increase in revenue and a 31% growth in North America system-wide sales compared to the same period in 2022. For the entire year of 2023, the company achieved a remarkable revenue growth of 30% and a 36% increase in North America system-wide sales.

Looking ahead to 2024, Xponential Fitness has ambitious plans to open 550 new studios, projecting a 22% growth in system-wide sales, an 8% revenue growth, and a substantial 31% increase in Adjusted EBITDA.

In conclusion, despite falling short of the EPS estimate, Xponential Fitness showcased strong sales performance and impressive revenue growth in Q4 2023 and throughout the full year. This positions the company for further expansion and success in the upcoming year.

XPOF Stock Shows Strong Performance and Positive Momentum on February 29, 2024

XPOF stock had a strong performance on February 29, 2024, as it closed at $10.08, marking a 3.49% increase from the previous trading day. After the market closed, XPOF continued to show positive momentum as it rose an additional $0.52 in after-hours trading. This further increase indicates that investors are optimistic about the future prospects of the company. Overall, the positive price momentum and after-hours trading performance of XPOF on February 29, 2024, suggest that the stock may have potential for further growth in the future. Investors should continue to monitor the stock closely to see how it performs in the coming days and weeks.

XPOF Stock Performance Review: Mixed Financial Metrics on February 29, 2024

XPOF stock had a mixed performance on February 29, 2024, with some key financial metrics showing improvement while others saw a decline. According to data from CNN Money, the company reported total revenue of $244.95 million for the past year, which represented a 57.95% increase compared to the previous year. However, total revenue for the most recent quarter was $80.44 million, indicating a 4.0% increase from the previous quarter.

On the other hand, XPOF’s net income for the past year was $22.16 million, reflecting a 17.86% decrease from the previous year. The most recent quarter showed a net loss of $20.16 million, representing a significant decline of 632.74% from the previous quarter.

Earnings per share (EPS) for XPOF also showed a mixed performance. The EPS for the past year was -$0.87, which was an improvement of 67.36% compared to the previous year. However, the EPS for the most recent quarter was -$0.50, indicating a decrease of 143.91% from the previous quarter.

Overall, XPOF’s stock performance on February 29, 2024, reflected a combination of positive and negative trends in key financial metrics. Investors may want to closely monitor the company’s financial performance in the coming quarters to assess its long-term growth prospects and investment potential.

Tags: XPOF
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Software-solutions-technology

CPSI Exceeds Expectations in Q4 2023 Financial Results

Technology Blockchain Stock Market Today

Dell Technologies Surprises Investors with Strong Q4 Results and Dividend Increase

Technology Blockchain Markets and money

NCR Voyix Reports Preliminary Revenue of 963 Million for Q4 2023 Just Under Projection

Recommended

CrowdStrike Stock

CrowdStrike’s AI Security Surge: Institutional Confidence Meets Insider Selling

2 months ago
Technology Artificial intelligence Market Capitalization

Nano Dimension Secures Repeat Sale with Major US Defense Company for 3D Printer

2 years ago
Finance_ Trading ratings today (2)

Navigating Market Volatility DermTechs Q4 Financial Results

2 years ago
Finance_ Trading ratings today (2)

Goldman Sachs Analyst Recommends Selling CalMaine Foods with Increased Price Target

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

FutureFuel Shares Maintain Upward Momentum as Strategy Gains Traction

A Strategic Stake and a Historic Discovery: Max Power Mining Gains Momentum

Synopsys Stock Navigates Strategic Shift Amid Divergent Investor Views

Southern Copper Shares Pause Ahead of Earnings Release

Analyst Downgrade Weighs on Intellia Therapeutics Shares

Fiserv Stock: A Critical Juncture for the Payments Giant

Trending

Sangamo Therapeutics Stock
Analysis

Can Sangamo Therapeutics Reach Profitability by 2027?

by Robert Sasse
January 20, 2026
0

Market analysts are pointing to a potential inflection point for Sangamo Therapeutics, with consensus estimates suggesting the...

Insmed Stock

Insmed Stock Analysis: Balancing Robust Revenue with Clinical Trial Volatility

January 20, 2026
MSCI World ETF Stock

A Global ETF’s American Heartbeat: How Tech Titans Drive the iShares MSCI World Fund

January 20, 2026
FutureFuel Stock

FutureFuel Shares Maintain Upward Momentum as Strategy Gains Traction

January 20, 2026
Max Power Mining Stock

A Strategic Stake and a Historic Discovery: Max Power Mining Gains Momentum

January 20, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Can Sangamo Therapeutics Reach Profitability by 2027?
  • Insmed Stock Analysis: Balancing Robust Revenue with Clinical Trial Volatility
  • A Global ETF’s American Heartbeat: How Tech Titans Drive the iShares MSCI World Fund

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com